ARCHIVES

Letrozole Cuts Risk Of Breast Cancer Recurrence Even After Tamoxifen Use

This article is from The Cancer Letter archive.

Vol. 31 No. 3 | March 28, 2008

Download PDF Visit The Full Archive

Related Articles

Alimta Granted Approval As NSCLC Continuation Therapy

November 25, 2011

FDA News: FDA Taking Comments on “First Generic” ANDA Process

November 21, 2014

In Brief: Kenneth Olden Named Director Of Howard Cancer Center; Calhoon Sparked AMA On Cigarette Ads

February 21, 1986

Klausner, Nathan Discuss Challenge of Cancer Research In the “Post-Genome World”

January 15, 1999

Colonoscopy Every Three Years Indicated For Those With Family History Of Polyps

May 31, 2002

DOD To Reimburse Care On Clinical Trials In Three-Year Deal

February 9, 1996